For this interview we spoke to Miguel Vasconcelos Da Silva who is a Registered Nurse, and Dementia and Related Disorders and Dementia Theme Manager in the Department of Old Age Psychiatry at the Institute of Psychiatry, Psychology & Neuroscience.
By
NIHR Maudsley BRC at 20 Jan 2021
Published on 17 November 2020, the Mild cognitive impairment: the Manchester consensus brings together expert views on how MCI should be recognised, diagnosed, and treated.
By
NIHR Maudsley BRC at 23 Nov 2020
£1.2 million in government funding will help researchers develop an innovative online programme to improve and personalise care for people with dementia in care homes, which were hard-hit by the COVID-19 crisis.
By
NIHR Maudsley BRC at 7 Oct 2020
An online study of 25,000 people is recruiting participants to help study the impact of COVID-19 isolation on the health and wellbeing of older people, and find new ways to support them.
By
NIHR Maudsley BRC at 15 May 2020
Researchers from the NIHR Maudsley BRC are to lead a pioneering new study into a cannabis-based treatment for people living with dementia. Alzheimer’s Research UK has awarded over £250,000 for the landmark phase II clinical trial of Sativex®, a cannabis-based medicine licenced in the UK. The drug has already been found to be safe in people and has been approved for use in the treatment of muscle stiffness and tightness experienced by people with multiple sclerosis. However, Sativex® is not currently licensed in the UK for any other indication, including treatment of the symptoms of dementia.
By
NIHR Maudsley BRC at 21 Feb 2019